Goknur Giner
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Redox regulation of EGFR activation by thioredoxin reductase 3 drives resistance to EGFR inhibitors in triple-negative breast cancer.
Journal: Cell death discovery
Published: November 06, 2025
ARAP2 regulates responses to interferon-gamma by restricting SOCS1.
Journal: Cell reports
Published: March 12, 2025
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma.
Journal: Nature communications
Published: October 30, 2024
Fibroblast hierarchy dynamics during mammary gland morphogenesis and tumorigenesis.
Journal: The EMBO journal
Published: September 16, 2024
A systematic review of computational methods for designing efficient guides for CRISPR DNA base editor systems.
Journal: Briefings in bioinformatics
Published: February 01, 2023
Author Correction: Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.
Journal: Nature communications
Published: August 25, 2022
Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.
Journal: Nature communications
Published: August 29, 2021
qtQDA: quantile transformed quadratic discriminant analysis for high-dimensional RNA-seq data.
Journal: PeerJ
Published: September 23, 2019
Targeting triple-negative breast cancers with the Smac-mimetic birinapant.
Journal: Cell death and differentiation
Published: June 10, 2019
Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 07, 2019
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer.
Journal: Science translational medicine
Published: January 06, 2017
RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.
Journal: Nature medicine
Published: February 29, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026